SHARON VENTURA: Open Payments
NPI 1417392127 · HARRINGTON PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 33 payments from 14 companies in 2025. Trend: 2023 $464 · 2024 $612 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $195 |
| Biosense Webster, Inc. | 5 | $189 |
| GlaxoSmithKline, LLC. | 2 | $140 |
| Novo Nordisk Inc | 1 | $122 |
| Astellas Pharma US Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: OTEZLA, CARTO 3, AREXVY, Wegovy, NUVISION ICE CATHETER, REXULTI, Veozah, NEXLETOL.
Industry payments across NJ — which companies pay providers there.
